Mindpeak
AI for pathology diagnosis
Hamburg, Germany
Mindpeak is a German health tech startup that develops AI-powered software for image recognition and analysis in digital pathology to improve cancer diagnostics.
How We Help
Problem Statement
The number of cancer experts is constant while the demand for medical image analysis is growing, leading to increased workloads. Mindpeak aims to improve the accuracy and speed of cancer diagnostics, reduce manual and repetitive tasks for pathologists, and enhance workflow efficiency.
Core Technology
Artificial Intelligence & Deep Learning
Key Differentiators
0-click solutions that work out-of-the-box without manual fine-tuning; Explainable AI (xAI) for transparency; Self-supervised learning methods
Clinical Focus
Pathology
Company Info
- Business Model
- Hybrid
- Total Funding
- 18,300,000
- Website
- www.mindpeak.ai
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
ASCO 2025 study with AstraZeneca demonstrated 40% improvement in HER2-ultralow case identification across 287 pathologists. Validated Ki-67 whole-slide scoring per IKWG protocol. Partnership with Discovery Life Sciences for clinical trial biomarker quantification. ISO 13485 certified.
MedStartr Index Score
?What do you think of Mindpeak?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.